NEW YORK ( TheStreet) -- InterMune (Nasdaq: ITMN) hit a new 52-week low Friday as it is currently trading at $10.56, below its previous 52-week low of $10.67 with 1.2 million shares traded as of 9:45 a.m. ET. Average volume has been 1.9 million shares over the past 30 days. InterMune has a market cap of $803 million and is part of the health care sector and drugs industry. Shares are down 1.2% year to date as of the close of trading on Thursday. InterMune, Inc., a biotechnology company, engages in the research, development, and commercialization of therapies in pulmonology and orphan fibrotic diseases. The company focuses on therapies for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter